Anivive
Edit

Anivive

http://anivive.com/
Last activity: 23.07.2021
Active
Categories: BioTechDevelopmentHealthTechPetProductResearchSoftwareSpecialty
Anivive discovers, develops and commercializes
specialty pet medicines.
Likes
346
Followers
47
Followers
16.6K
Website visits
34.3K /mo.
Mentions
8
Location: United States, California, Long Beach
Employees: 11-50
Phone: +1 866-264-8483
Founded date: 2015
Twitter
Facebook
Instagram
LinkedIn
Email

Investors 1

Mentions in press and media 8

DateTitleDescription
23.07.2021Anivive's GC376 Reduces COVID-19 Replication, Shows Potential as New Post-Infection Treatment
08.07.2021Anivive Announces Publication Highlighting The First Successful Use Of Artificial Intelligence In Diagnosing Valley Fever In Dogs– Anivive strategically paired software technology with a therapeutic in development – Rapid recognition of Coccidioides infection in dogs may ultimately lead to human detection – Machine learning allows for accurate and interpretable predi...
07.07.2021Anivive Announces Publication Highlighting the First Successful Use of Artificial Intelligence in Diagnosing Valley Fever in Dogs
29.06.2021Anivive Expands Specialty Sales Team to Support Rapid National Distribution of LAVERDIA™-CA1 (verdinexor)LONG BEACH, Calif., June 28, 2021 /PRNewswire/ -- To meet demand and help veterinarians incorporate a novel treatment for canine lymphoma, Anivive has expanded its specialty sales team to increase availability for customers in 10 key market...
28.06.2021Anivive Expands Specialty Sales Team to Support Rapid National Distribution of LAVERDIA™-CA1 (verdinexor)
17.06.2021Anivive Announces Positive Study Results for Antifungal Vaccine to Prevent Canine Valley Fever
26.05.2021Anivive Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Newest Lymphoma Treatment for Dogs
21.01.2021Anivive Announces FDA Conditional Approval of LAVERDIA™-CA1 (verdinexor) - the First and Only Oral Tablet to Treat Lymphoma in Dogs

Reviews 0

Sign up to leave a review

Sign up Log In